Search

everythinglearnresearchcommunity

for

Search:↓

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Autoinflammatory skin diseases are complex, increasingly common, and significantly affect quality of life.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

MCHR2 gene duplications may be linked to alopecia areata.

Non-coding RNAs may be key in diagnosing and treating rare skin disorders.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

A specific gene change is linked to severe hair loss.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Recent dermatological research highlights include new virus discoveries, genetic links to skin conditions, and insights into skin healing and pigmentation.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

A rare genetic mutation causes severe immune issues, hair loss, and nail problems.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

A new mouse model effectively mimics vitiligo for research and drug testing.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

The research concluded that selection significantly shaped the genetic variation of the X chromosome, with certain regions affected by past selective events.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

The research provided new insights into the genetic factors contributing to hair loss and skin conditions by analyzing individual cells from the human scalp.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Genetic factors could lead to personalized treatments for hair loss.

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.